13F COMBINATION REPORT
Syncona Portfolio Ltd
Quarter ended Q4 2023 · Filed November 1, 2023 · Accession 0000950123-23-009265
Total Value
$67.1M
Positions
4
Other Managers
3
Confidential Omitted
No
Holdings (4)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | AUTOLUS THERAPEUTICS PLC | AUTL | 21,346,829 | $49.7M | 74.11% |
| 2 | ACHILLES THERAPEUTICS PLC | 00449L102 | 11,086,909 | $10.1M | 15.03% |
| 3 | FREELINE THERAPEUTICS HLDGS | 35655L107 | 1,466,507 | $6.2M | 9.26% |
| 4 | ADAPTIMMUNE THERAPEUTICS PLC | ADTI | 1,377,294 | $1.1M | 1.60% |